UPDATE 1-US FDA approves expanded use of Bristol's cancer cell therapy [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Bristol Myers Squibb's cancer cell therapy Breyanzi for the treatment of adults with a type of blood cancer that has returned or has not responded to prior treatments. The Food and Drug Administration's decision marks the fourth approval for Breyanzi. It was first approved in the United States in 2021 as a second-line treatment for a type of blood cancer known as large B-cell lymphoma. The therapy belongs to a class of drugs known as chimeric antigen receptor (CAR) T-cell therapies that work by modifying white blood cells known as T-cells to attack cancer. (Reporting by Sneha S K and Bhanvi Satija in Bengaluru; Editing by Shailesh Kuber)
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Why Bristol Myers Squibb Is A Top Socially Responsible Dividend Stock [Forbes]Forbes
- Insights From Global Life Sciences Benchmarking: Experts and End Users to Discuss Emerging Trends and Benefits [Yahoo! Finance]Yahoo! Finance
- Biotech M&A Slumps 40% as Drugmakers Take a Break From Public Deals [BNN Bloomberg (Canada)]BNN Bloomberg
- CAR-T Cell Therapy Market to Achieve USD 85.8 Billion by 2033, Driven by 32.0% CAGR | Dimension Market Research [Yahoo! Finance]Yahoo! Finance
- Bristol Myers: Quality Fundamentals Suppressed By Interest Rates [Seeking Alpha]Seeking Alpha
BMY
Earnings
- 4/25/24 - Miss
BMY
Sec Filings
- 5/9/24 - Form 8-K
- 5/3/24 - Form 4
- 4/25/24 - Form 10-Q
- BMY's page on the SEC website